Enanta Pharmaceuticals Inc (ENTA)
Operating Cash Flow (Statement)
-$9.97M
Quarterly · Period ending: · USD
ENTA Operating Cash Flow (Statement)
Latest reported-$9.97Mperiod ending
Latest reported-$9.97Mperiod ending
ENTA Quarterly Cash from Operations (-$3.64M → -$9.97M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
ENTA operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -9,972,000 | |
| -7,156,000 | |
| -11,699,000 | |
| -6,489,000 | |
| 17,506,000 | |
| -13,488,000 | |
| -16,801,000 | |
| -10,400,000 | |
| -14,775,000 | |
| -28,601,000 | |
| -24,988,000 | |
| -21,602,000 | |
| -32,128,000 | |
| -13,783,000 | |
| -35,641,000 | |
| -15,534,000 | |
| -29,602,000 | |
| -26,375,000 | |
| -13,271,000 | |
| -21,021,000 | |
| -29,506,000 | |
| -4,579,000 | |
| -14,890,000 | |
| -15,461,000 | |
| -4,488,000 | |
| 14,674,000 | |
| 12,363,000 | |
| 8,545,000 | |
| 2,533,000 | |
| 30,086,000 | |
| 30,254,000 | |
| 28,341,000 | |
| 4,048,000 | |
| -7,578,000 | |
| 4,409,000 | |
| 57,306,000 | |
| -4,796,000 | |
| -3,002,000 | |
| 3,145,000 | |
| -2,126,000 | |
| -2,112,000 | |
| 10,054,000 | |
| 29,993,000 | |
| -2,375,000 | |
| -14,203,000 | |
| 98,861,000 | |
| -5,610,000 | |
| -4,932,000 | |
| 35,112,000 | |
| -4,130,000 | |
| -5,871,000 | |
| -2,503,000 | |
| -5,922,000 | |
| 10,033,000 | |
| 9,045,000 | |
| -1,702,000 | |
| -3,828,000 | |
| 31,341,000 | |
| -3,188,000 | |
| -3,640,000 |